Furthermore, recent evidence has demonstrated that serum adipolin levels decrease in type 2 diabetes, CVDs, and polycystic ovary syndrome (PCOS) disorders [16,17,18]. This evidence concerns the gene C1QTNF12 and type 2 diabetes mellitus.